The coronary drug eluting stent market is estimated to be worth $3.8 billion in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 9.26% during the forecast period. Our market study report aims to deliver value-pack information about supply chain ratio, product portfolio, consumption pattern, purchasing habits, macro and micro-economic factors. The global Coronary Drug Eluting Stent market report highlights the discussion on the top segments across the Coronary Drug Eluting Stent industry and the major share held by the segments by Distribution by Type of Drug Eluted (Sirolimus, Paclitaxel, Everolimus, Zotarolimus and Others)
もっと見る
コメント